The global virology market is on track for significant expansion, with projections indicating a steady rise from USD 2,333.2 ...
Hepatitis B is a liver infection cause by the hepatitis B virus (HBV), and long-term hepatitis B infections that last longer ...
Hepatitis B is a liver infection caused by the hepatitis B virus (HBV), and long-term hepatitis B infections that last longer ...
Tivoxavir marboxil (TXM), administered as a single dose in non-human primates, significantly reduced lung viremia and prevented weight loss, two ...
Chronic hepatitis B (CHB) is currently estimated to affect over 250 million people worldwide, and tenofovir disoproxil ...
The COVID-19 pandemic highlighted the urgent need for effective therapeutic agents against SARS-CoV-2. Although vaccines ...
This site uses cookies to enhance your user experience. By continuing to use this site you are agreeing to our COOKIE POLICY.
Poster underscores Tivoxavir Marboxil’s potential for the treatment of bird flu, supported by 100% survival in a rodent challenge model, potent ...
Gene therapy, with its offer of a possible cure for rare diseases like sickle cell, is losing early investors to ...
Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for ...
Back in 2021, at the height of the pandemic, scientists at Pfizer revealed the development of a novel antiviral molecule, ...
Based on the feedback received, this document may change. Learn about the consultation. Drugs included on the list for exceptional importation and sale are called "designated drugs". They are eligible ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback